Atlas Trials

Comparison of Once-Weekly Trelagliptin vs. Once-Daily Vildagliptin for HbA1c Reduction in Type 2 Diabetes

Clinical trial NCT06913101 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06913101
Sponsor
PNS Hafeez - Naval Hospital
Status
ACTIVE_NOT_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Type 2 Diabetes Mellitus (T2DM)
Start date
2024-11-15
Primary completion
2025-05-15
Enrollment
102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.